Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Professor Newell-Price, new President-elect at The Endocrine Society
Listen and Learn from Patients: An interview with Professor Newell-Price, new President-elect at The Endocrine Society "Trained by Titans of Clinical Endocrinology" John Newell-Price is Professor of Endocrinology at the University of Sheffield, and is an Honorary...
Episode 2 of the ‘Not Just NE Cancer Takeover Series’ Explores RareCan’s Innovative Research Platform
We are excited to announce that Episode 2 of the "Not Just NE Cancer Takeover Series" is now live! In this captivating episode, our Campaigns Lead, Lisa engages in a thought-provoking discussion with Andy Hall, Co-founder & Chief Scientific Officer of RareCan, a...
Join the Pathway Virtual Challenge and Support Neuroendocrine Cancer Research!
We are thrilled to announce the launch of the Pathway Virtual Challenge, an exciting nationwide event aimed at advancing neuroendocrine cancer research and making a real difference in the lives of those affected by this complex disease. Neuroendocrine Cancer UK...